Yes, another inquiry. They infected them with malaria and they gave them mefloquine. It stops malaria. It treats malaria, so it's a good drug for both treating and preventing malaria. Then they gave it to Hoffman-LaRoche.
Hoffman-LaRoche was in a hurry to get it out. It really bypassed the pivotal phase, what are called phase three studies, which it should have carried out on tourists because that's the anticipated population. There were no pivotal randomized controlled trials of the drug on tourists until 2001, when another company did a trial.